Subscribe To
Nls pharmaceutics to present interim top-line data for quilience(r) (mazindol er) in patients with narcolepsy at the world sleep congress in march 2022
Phase 2a trial meets enrollment target for interim analysis and is now more than 50% enrolled 21 clinical sites in the United States actively enrollin...
February 7, 2022, 7:30 am
Nls pharmaceutics to present interim top-line data for quilience(r) (mazindol er) in patients with narcolepsy at the world sleep congress in march 2022
Phase 2a trial meets enrollment target for interim analysis and is now more than 50% enrolled 21 clinical sites in the United States actively enrollin...
February 7, 2022, 7:30 am
These 3 reits pay you each month
Total return and 12 payoffs a year make these candidates for a long-term play....
February 6, 2022, 8:15 am
These 3 reits pay you each month
Total return and 12 payoffs a year make these candidates for a long-term play....
February 6, 2022, 8:15 am
These 3 reits pay you each month
Total return and 12 payoffs a year make these candidates for a long-term play....
February 6, 2022, 8:15 am
Valneva - pfizer choose three-dose schedule for lyme vaccine candidate moving forward
Valneva SE VALN and Pfizer Inc PFE have reported further Phase 2 data for their Lyme disease vaccine cand...
February 4, 2022, 8:54 am
Valneva - pfizer choose three-dose schedule for lyme vaccine candidate moving forward
Valneva SE VALN and Pfizer Inc PFE have reported further Phase 2 data for their Lyme disease vaccine cand...
February 4, 2022, 8:54 am
Valneva - pfizer choose three-dose schedule for lyme vaccine candidate moving forward
Valneva SE VALN and Pfizer Inc PFE have reported further Phase 2 data for their Lyme disease vaccine cand...
February 4, 2022, 8:54 am
Verona pharma: first inhaled product candidate combining anti-inflammatory and bronchodilator effects, a potential blockbuster
he company's lead product candidate is Ensifentrine, an inhaled PDE3, and PDE4 inhibitor, which is bein...
February 3, 2022, 7:00 pm
Verona pharma: first inhaled product candidate combining anti-inflammatory and bronchodilator effects, a potential blockbuster
he company's lead product candidate is Ensifentrine, an inhaled PDE3, and PDE4 inhibitor, which is bein...
February 3, 2022, 7:00 pm
Verona pharma: first inhaled product candidate combining anti-inflammatory and bronchodilator effects, a potential blockbuster
he company's lead product candidate is Ensifentrine, an inhaled PDE3, and PDE4 inhibitor, which is bein...
February 3, 2022, 7:00 pm
Pardes biosciences clears ind application for oral antiviral candidate for covid-19
The FDA has signed off Pardes Biosciences Inc's PRDS Investigational New Drug (IND) application for PBI-0451 for COVID-19. Get the Inside Access Tr...
February 3, 2022, 11:45 am
Pardes biosciences clears ind application for oral antiviral candidate for covid-19
The FDA has signed off Pardes Biosciences Inc's PRDS Investigational New Drug (IND) application for PBI-0451 for COVID-19. Get the Inside Access Tr...
February 3, 2022, 11:45 am
Pardes biosciences clears ind application for oral antiviral candidate for covid-19
The FDA has signed off Pardes Biosciences Inc's PRDS Investigational New Drug (IND) application for PBI-0451 for COVID-19. Get the Inside Access Tr...
February 3, 2022, 11:45 am
Mindset pharma identifies additional drug candidates from 'family 3' compounds
Mindset Pharma Inc (CSE:MSET, OTCQB:MSSTF) announced that it has synthesized additional promising candid...
February 3, 2022, 8:49 am
Mindset pharma identifies additional drug candidates from 'family 3' compounds
Mindset Pharma Inc (CSE:MSET, OTCQB:MSSTF) announced that it has synthesized additional promising candid...
February 3, 2022, 8:49 am
Mindset pharma identifies additional drug candidates from 'family 3' compounds
Mindset Pharma Inc (CSE:MSET, OTCQB:MSSTF) announced that it has synthesized additional promising candid...
February 3, 2022, 8:49 am
Vgt vs. vti: is tech or broad market exposure best right now?
Over the last 18 years, tech has been the clear winner, but interest appears to be shifting towards the broader markets. VTI is a better ...
February 2, 2022, 9:30 am
Vgt vs. vti: is tech or broad market exposure best right now?
Over the last 18 years, tech has been the clear winner, but interest appears to be shifting towards the broader markets. VTI is a better ...
February 2, 2022, 9:30 am
Vgt vs. vti: is tech or broad market exposure best right now?
Over the last 18 years, tech has been the clear winner, but interest appears to be shifting towards the broader markets. VTI is a better ...
February 2, 2022, 9:30 am